TABRECTA FILM-COATED TABLET 200mg
Product details
Registration number: SIN16351P
Classification: Prescription Only
Active ingredients: Capmatinib dihydrochloride monohydrate eqv Capmatinib
Strength: 200mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: NOVARTIS (SINGAPORE) PTE LTD
ATC code: L01EX17
HSA approval date: 22 October 2021
Manufacturer(s):
- Lek d.d. (Primary and Secondary Packager)
- Novartis Pharma Produktions GmbH
- Novartis Pharmaceuticals S.R.L.
Manufacturing country/countries: SLOVENIA; GERMANY; ROMANIA
What are the HSA registration number and classification for TABRECTA FILM-COATED TABLET 200mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16351P
Classification: Prescription Only
What active ingredients and strength are recorded for TABRECTA FILM-COATED TABLET 200mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Capmatinib dihydrochloride monohydrate eqv Capmatinib
Strength: 200mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TABRECTA FILM-COATED TABLET 200mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for TABRECTA FILM-COATED TABLET 200mg?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for TABRECTA FILM-COATED TABLET 200mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Lek d.d. (Primary and Secondary Packager)
- Novartis Pharma Produktions GmbH
- Novartis Pharmaceuticals S.R.L.
Manufacturing country/countries: SLOVENIA; GERMANY; ROMANIA
Where can I look up TABRECTA FILM-COATED TABLET 200mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16351P or the exact product name TABRECTA FILM-COATED TABLET 200mg. The general register link does not preselect this product.
What are the source dates for this TABRECTA FILM-COATED TABLET 200mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TABRECTA FILM-COATED TABLET 200mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16351P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)